These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2089839)

  • 21. Combined chlorpropamide-insulin in the treatment of non-insulin-dependent diabetes mellitus with secondary failure of sulfonylurea therapy.
    Jiraratsatit J; Keoplung M; Chumsilp L; Chomchoengpatya P; Matayabun S
    J Med Assoc Thai; 1986 Dec; 69(12):627-34. PubMed ID: 3553408
    [No Abstract]   [Full Text] [Related]  

  • 22. Rationale for the association of sulfonylurea and insulin.
    Del Prato S
    Am J Med; 1991 Jun; 90(6A):77S-82S. PubMed ID: 1872309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Aug; 29(8):1990-1. PubMed ID: 16873829
    [No Abstract]   [Full Text] [Related]  

  • 24. Initial management of glycemia in type 2 diabetes.
    Banarer S
    N Engl J Med; 2003 Feb; 348(8):760-1; author reply 760-1. PubMed ID: 12594327
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
    Farooki A; Schneider SH
    Diabetes Care; 2006 Aug; 29(8):1989-90. PubMed ID: 16873827
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of metformin in type II diabetes.
    Epstein S
    Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic management of the secondary failure of sulfonylurea therapy].
    Sauer H
    Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin in the early management of diabetic complications.
    Miles JM
    J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes care: what should we try to achieve?
    O'Connor PJ
    J Fam Pract; 1991 Oct; 33(4):343-4. PubMed ID: 1919448
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfonylureas in the treatment of diabetes mellitus--1985.
    Gerich JE
    Mayo Clin Proc; 1985 Jul; 60(7):439-43. PubMed ID: 3925246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 34. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy of diabetes mellitus in "secondary failure of sulfonylurea compounds"].
    Bachmann W
    Med Klin (Munich); 1987 Jun; 82(14):491-4. PubMed ID: 3302644
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin combination therapy in type 2 diabetes mellitus.
    Hassan Y; Gupta G; Hassan S
    Ann Intern Med; 2004 Apr; 140(8):666; author reply 667. PubMed ID: 15096346
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin combination therapy in type 2 diabetes mellitus.
    Mikhail N; Wali S
    Ann Intern Med; 2004 Apr; 140(8):666-7; author reply 667. PubMed ID: 15096347
    [No Abstract]   [Full Text] [Related]  

  • 38. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
    Menon KN; Seshadri MS
    J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.
    Riddle MC
    Horm Metab Res; 1996 Sep; 28(9):430-3. PubMed ID: 8911978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin: either alone or combined with oral hypoglycemic agents.
    Firth RG
    Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.